Legend Biotech's 15min Chart Sees MACD & KDJ Death Cross

Legend Biotech's 15-minute chart has recently triggered a MACD Death Cross and a KDJ Death Cross, as of August 20, 2025, at 10:15. This indicates a potential continuation of the downward trend in the stock price, with momentum shifting in favor of a further decrease.

Legend Biotech has appointed Carlos Santos as its new Chief Financial Officer (CFO), effective immediately. Santos, a seasoned executive with extensive experience at AstraZeneca, Alcon, and Intel, will succeed Jessie Yeung, who served as interim CFO since January [1]. Santos' appointment comes as the company's stock has been showing signs of a downward trend, as indicated by recent technical indicators.

Santos brings a wealth of financial leadership experience to Legend Biotech. At AstraZeneca, he served as CFO for U.S. oncology and previously held the position of acting area vice president for Latin America. His compensation package includes a base salary of $500,000, with a potential annual bonus worth 45% of his salary. Starting in 2026, Santos can receive an annual stock grant anticipated to be worth at least $1 million [1].

Technical indicators, such as the MACD Death Cross and the KDJ Death Cross, have recently been triggered on Legend Biotech's 15-minute chart, as of August 20, 2025, at 10:15. These indicators suggest a potential continuation of the downward trend in the stock price, with momentum shifting in favor of a further decrease [2].

References:
[1] https://www.marketscreener.com/news/legend-biotech-taps-astrazeneca-executive-for-cfo-ce7c51dcd98efe21
[2] https://www.marketscreener.com/news/legend-biotech-15-minute-chart-triggers-macd-and-kdj-death-crosses-august-20-2025-1015